Your browser version may not work well with NCBI's Web applications. More information here...
1: Compr Ther. 2001 Fall;27(3):195-201.Links

Promoting informed decision making about prostate cancer screening.

Division of General Internal Medicine, Department of Medicine, University of Texas-Houston Health Science Center, 6431 Fannin, 1.122 MSB, Houston, TX 77030, USA.

Because prostate cancer screening with prostate specific antigen is controversial, informed consent is recommended. Physicians are encouraged to discuss facts about prostate specific antigen with patients and to supplement such discussions with informational brochures or videotapes.

PMID: 11569319 [PubMed - indexed for MEDLINE]